Catalyst Wire Dossier Catalyst Wire Dossier

TAF/EVG Vaginal Insert

tenofovir alafenamide/elvitegravir vaginal insert · Eastern Virginia Medical School
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAF/EVG Vaginal Insert, covering 2025-09-02 to 2025-09-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety and PK Multi-dose Study of TAF/EVG Vaginal Insert [Phase 1]

See pricing